This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply GARDASIL 9 syringes to the Defense Logistics Agency (DLA). The $9,450.26 firm fixed-price delivery order was awarded on December 20, 2024, with a completion date of December 23, 2024. This award is under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition.
Generated 3/21/25, 9:47 AM